D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 48 Citations 6,990 110 World Ranking 3613 National Ranking 253

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Internal medicine
  • Gene

His primary scientific interests are in Microbiology, Internal medicine, Community-acquired pneumonia, Antibacterial agent and Intensive care medicine. His Microbiology research is multidisciplinary, incorporating elements of Legionella pneumophila, Cell culture, Enterococcus faecalis and Virology. His research integrates issues of Gastroenterology and Surgery in his study of Internal medicine.

His studies in Antibacterial agent integrate themes in fields like Bacteremia, Medical microbiology, Neutropenia and Antibiotic resistance. The various areas that Reinhard Marre examines in his Intensive care medicine study include Respiratory disease, Epidemiology, Ambulatory, Legionnaires' disease and Prospective cohort study. His work carried out in the field of Epidemiology brings together such families of science as Legionella and Legionella Pneumonia.

His most cited work include:

  • Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. (229 citations)
  • Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes (221 citations)
  • CRB-65 predicts death from community-acquired pneumonia. (211 citations)

What are the main themes of his work throughout his whole career to date?

Reinhard Marre focuses on Microbiology, Internal medicine, Community-acquired pneumonia, Intensive care medicine and Legionella pneumophila. Reinhard Marre is interested in Antibiotic resistance, which is a branch of Microbiology. His Internal medicine research integrates issues from Surgery, Antibacterial agent, Immunology and Gastroenterology.

His biological study spans a wide range of topics, including Respiratory disease, Prospective cohort study, Procalcitonin and Epidemiology. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Guideline, Respiratory tract infections, Respiratory system and Antimicrobial. His Legionella pneumophila research is multidisciplinary, relying on both Legionella, Molecular biology and Mutant.

He most often published in these fields:

  • Microbiology (45.87%)
  • Internal medicine (24.77%)
  • Community-acquired pneumonia (22.94%)

What were the highlights of his more recent work (between 2005-2016)?

  • Community-acquired pneumonia (22.94%)
  • Internal medicine (24.77%)
  • Intensive care medicine (13.76%)

In recent papers he was focusing on the following fields of study:

Reinhard Marre mainly investigates Community-acquired pneumonia, Internal medicine, Intensive care medicine, Epidemiology and Microbiology. His study in Community-acquired pneumonia is interdisciplinary in nature, drawing from both Multivariate analysis, Pharmacotherapy, Respiratory system, Prospective cohort study and Etiology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Surgery and Immunology.

Reinhard Marre interconnects Legionella, Respiratory tract infections and Antimicrobial in the investigation of issues within Intensive care medicine. His Epidemiology research incorporates themes from Legionella Pneumonia and Population study. His work deals with themes such as Legionella pneumophila and Gene, which intersect with Microbiology.

Between 2005 and 2016, his most popular works were:

  • Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes (221 citations)
  • CRB-65 predicts death from community-acquired pneumonia. (211 citations)
  • Community-Acquired Legionella Pneumonia: New Insights from the German Competence Network for Community Acquired Pneumonia (158 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Internal medicine
  • Gene

His scientific interests lie mostly in Internal medicine, Community-acquired pneumonia, Epidemiology, Intensive care medicine and Respiratory disease. Reinhard Marre regularly ties together related areas like Surgery in his Internal medicine studies. His research in Epidemiology intersects with topics in Medical microbiology, Mycoplasma pneumoniae, Antibacterial agent and Environmental health.

His Intensive care medicine research includes themes of Mortality rate, Multivariate analysis, Antimicrobial and Blood pressure. His Respiratory disease research includes elements of Legionella, Legionella pneumophila, Legionnaires' disease, Legionella Pneumonia and Ambulatory. His C-reactive protein study combines topics in areas such as Gastroenterology and Area under the curve.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CRB-65 predicts death from community-acquired pneumonia.

T. T. Bauer;S. Ewig;R. Marre;N. Suttorp.
Journal of Internal Medicine (2006)

411 Citations

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

S Krüger;S Ewig;R Marre;J Papassotiriou.
European Respiratory Journal (2008)

350 Citations

Detection of Legionellae in Hospital Water Samples by Quantitative Real-Time LightCycler PCR

Nele Wellinghausen;Cathrin Frost;Reinhard Marre.
Applied and Environmental Microbiology (2001)

312 Citations

In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms.

M Lauterwein;M Oethinger;K Belsner;T Peters.
Antimicrobial Agents and Chemotherapy (1995)

282 Citations

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

W V Kern;E Andriof;M Oethinger;P Kern.
Antimicrobial Agents and Chemotherapy (1994)

266 Citations

Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations

A. Erb;T. Stürmer;R. Marre;H. Brenner.
European Journal of Clinical Microbiology & Infectious Diseases (2007)

249 Citations

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

H Kothe;T Bauer;R Marre;N Suttorp.
European Respiratory Journal (2008)

249 Citations

Community-Acquired Legionella Pneumonia: New Insights from the German Competence Network for Community Acquired Pneumonia

Heike von Baum;Santiago Ewig;Reinhard Marre;Norbert Suttorp.
Clinical Infectious Diseases (2008)

246 Citations

Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst.

Sigurd D. Süßmuth;Albrecht Muscholl-Silberhorn;Reinhard Wirth;Milorad Susa.
Infection and Immunity (2000)

226 Citations

Antimicrobial resistance of Escherichia coli and therapeutic implications.

Heike von Baum;Reinhard Marre.
International Journal of Medical Microbiology (2005)

223 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Reinhard Marre

Tobias Welte

Tobias Welte

University of Hannover

Publications: 67

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 46

Carmen Buchrieser

Carmen Buchrieser

Institut Pasteur

Publications: 34

Norbert Suttorp

Norbert Suttorp

Charité - University Medicine Berlin

Publications: 34

Philipp Schuetz

Philipp Schuetz

University of Basel

Publications: 33

Ulrich Zähringer

Ulrich Zähringer

Research Center Borstel - Leibniz-Center for Medicine and Biosciences

Publications: 27

Hubert Hilbi

Hubert Hilbi

University of Zurich

Publications: 22

Kenneth V. I. Rolston

Kenneth V. I. Rolston

The University of Texas MD Anderson Cancer Center

Publications: 20

Jordi Carratalà

Jordi Carratalà

University of Barcelona

Publications: 20

Francesco Blasi

Francesco Blasi

University of Milan

Publications: 19

Martin Witzenrath

Martin Witzenrath

Charité - University Medicine Berlin

Publications: 19

Gilbert Greub

Gilbert Greub

University of Lausanne

Publications: 19

Michael S. Niederman

Michael S. Niederman

Cornell University

Publications: 19

Jörg Hacker

Jörg Hacker

University of Würzburg

Publications: 19

Jordi Rello

Jordi Rello

Instituto de Salud Carlos III

Publications: 18

Mirjam Christ-Crain

Mirjam Christ-Crain

University of Basel

Publications: 17

Trending Scientists

Tom Schaul

Tom Schaul

DeepMind (United Kingdom)

Takao Yamada

Takao Yamada

Nichia Corporation (Japan)

Jana Koehler

Jana Koehler

German Research Centre for Artificial Intelligence

Reşat Apak

Reşat Apak

Istanbul University

Talat S. Rahman

Talat S. Rahman

University of Central Florida

Imre G. Csizmadia

Imre G. Csizmadia

University of Toronto

Stephen L. Leib

Stephen L. Leib

University of Bern

Constantino Mpodozis

Constantino Mpodozis

University of Chile

Tommy D. Dickey

Tommy D. Dickey

University of California, Santa Barbara

Mao-Chang Liang

Mao-Chang Liang

Academia Sinica

David P. Krabbenhoft

David P. Krabbenhoft

United States Geological Survey

Brian Hjelle

Brian Hjelle

University of New Mexico

Cecilia L. W. Chan

Cecilia L. W. Chan

University of Hong Kong

Elvio G. Silva

Elvio G. Silva

The University of Texas MD Anderson Cancer Center

Joshua D. Simon

Joshua D. Simon

Carnegie Institution for Science

Robert C. Myers

Robert C. Myers

Perimeter Institute

Something went wrong. Please try again later.